10.6084/m9.figshare.c.3783488_D4.v1
Virginie Nägele
Virginie
Nägele
Andrea Kratzer
Andrea
Kratzer
Gerhard Zugmaier
Gerhard
Zugmaier
Chris Holland
Chris
Holland
Youssef Hijazi
Youssef
Hijazi
Max Topp
Max
Topp
Nicola Gökbuget
Nicola
Gökbuget
Patrick Baeuerle
Patrick
Baeuerle
Peter Kufer
Peter
Kufer
Andreas Wolf
Andreas
Wolf
Matthias Klinger
Matthias
Klinger
MOESM4 of Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL
Springer Nature
2017
Acute lymphoblastic leukemia
Blinatumomab
Bispecific
BiTE®
CD19
Liver enzymes
Pharmacodynamics
2017-05-18 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/MOESM4_of_Changes_in_clinical_laboratory_parameters_and_pharmacodynamic_markers_in_response_to_blinatumomab_treatment_of_patients_with_relapsed_refractory_ALL/5024294
Additional file 4. Available patient numbers (N) for analysis of distribution profiles of CD8+ and CD4+ T cells and subsets in Fig. 4.